AR046494A1 - Metodo para la preparacion de mirtazapina enantiomericamente pura (1,2,3,4,10,14b-hexahidro-2-metil-pirazino[2,1-a]pirido[2,3-c][2]benzazepina - Google Patents

Metodo para la preparacion de mirtazapina enantiomericamente pura (1,2,3,4,10,14b-hexahidro-2-metil-pirazino[2,1-a]pirido[2,3-c][2]benzazepina

Info

Publication number
AR046494A1
AR046494A1 ARP040102412A ARP040102412A AR046494A1 AR 046494 A1 AR046494 A1 AR 046494A1 AR P040102412 A ARP040102412 A AR P040102412A AR P040102412 A ARP040102412 A AR P040102412A AR 046494 A1 AR046494 A1 AR 046494A1
Authority
AR
Argentina
Prior art keywords
preparation
enantiomerically pure
benzazepina
hexahidro
pirazino
Prior art date
Application number
ARP040102412A
Other languages
English (en)
Inventor
J H Wieringa
De Ven A A M Van
G J Kemperman
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR046494A1 publication Critical patent/AR046494A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Método para la preparación de mirtazapina enantioméricamente pura, dicho método comprende un paso de cierre del anillo de un compuesto de la fórmula (1), donde X es un grupo saliente, dicho paso comprende el tratamiento con un ácido, y por el cual se forma mirtazapina con exceso enantiomérico por el cierre del anillo del compuesto de fórmula (1) con exceso enantiomérico, mediante el tratamiento con un ácido adecuado en ausencia de solvente o una combinación adecuada de un ácido y un solvente orgánico.
ARP040102412A 2003-07-10 2004-07-08 Metodo para la preparacion de mirtazapina enantiomericamente pura (1,2,3,4,10,14b-hexahidro-2-metil-pirazino[2,1-a]pirido[2,3-c][2]benzazepina AR046494A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102095 2003-07-10

Publications (1)

Publication Number Publication Date
AR046494A1 true AR046494A1 (es) 2005-12-14

Family

ID=34042934

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102412A AR046494A1 (es) 2003-07-10 2004-07-08 Metodo para la preparacion de mirtazapina enantiomericamente pura (1,2,3,4,10,14b-hexahidro-2-metil-pirazino[2,1-a]pirido[2,3-c][2]benzazepina

Country Status (36)

Country Link
US (2) US8058436B2 (es)
EP (1) EP1656365B1 (es)
JP (1) JP4668184B2 (es)
KR (1) KR20060056315A (es)
CN (1) CN100558722C (es)
AR (1) AR046494A1 (es)
AT (1) ATE433965T1 (es)
AU (1) AU2004255874B2 (es)
BR (1) BRPI0412447A (es)
CA (1) CA2531165C (es)
CO (1) CO5640123A2 (es)
CY (1) CY1109327T1 (es)
DE (1) DE602004021605D1 (es)
DK (1) DK1656365T3 (es)
EC (1) ECSP066271A (es)
ES (1) ES2327123T3 (es)
HK (1) HK1086841A1 (es)
HR (1) HRP20051019A2 (es)
IL (1) IL172549A0 (es)
IS (1) IS2674B (es)
LT (1) LT5382B (es)
LV (1) LV13441B (es)
MX (1) MXPA06000325A (es)
NO (1) NO20056175L (es)
NZ (1) NZ544360A (es)
PE (1) PE20050323A1 (es)
PL (1) PL1656365T3 (es)
PT (1) PT1656365E (es)
RS (1) RS20050972A (es)
RU (1) RU2352566C2 (es)
SG (1) SG144914A1 (es)
SI (1) SI1656365T1 (es)
TW (1) TWI335915B (es)
UA (1) UA83666C2 (es)
WO (1) WO2005005410A1 (es)
ZA (1) ZA200600019B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102153620A (zh) * 2005-09-26 2011-08-17 住友化学株式会社 光学活性的哌嗪化合物的制造方法
JP5080050B2 (ja) * 2005-09-26 2012-11-21 住友化学株式会社 光学活性なピペラジン化合物の製造方法
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
EP2119709A4 (en) * 2007-02-09 2011-08-17 Kaneka Corp PROCESS FOR PREPARING OPTICALLY ACTIVE 2-ARYLPIPERAZINE DERIVATIVE
JP5192707B2 (ja) * 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
JP5635905B2 (ja) * 2007-04-11 2014-12-03 メルク・シャープ・エンド・ドーム・ベー・フェー ミルタザピンの調製方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów
KR102540021B1 (ko) * 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
TW206227B (es) * 1989-10-05 1993-05-21 Sankyo Co
BR9815098A (pt) 1997-11-14 2000-10-10 Akzo Nobel Nv Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
US20030069417A1 (en) * 1999-04-19 2003-04-10 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
CA2368815A1 (en) * 1999-04-19 2000-10-26 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
US6068695A (en) * 1999-07-13 2000-05-30 Bayer Corporation Process for the continuous preparation of quinacridones
WO2001025185A1 (fr) 1999-09-30 2001-04-12 Sumika Fine Chemicals Co., Ltd. Procede de production de derive de piperazine
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
CA2396209C (en) 2000-02-11 2009-09-01 Akzo Nobel N.V. The use of mirtazapine for the treatment of sleep disorders
JP2001342188A (ja) * 2000-03-27 2001-12-11 Takeda Chem Ind Ltd 縮合ピラゾール誘導体、その製造法および用途
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
DE602004021605D1 (de) 2009-07-30
US8058436B2 (en) 2011-11-15
IL172549A0 (en) 2006-04-10
CY1109327T1 (el) 2014-07-02
IS2674B (is) 2010-09-15
CN100558722C (zh) 2009-11-11
CO5640123A2 (es) 2006-05-31
US20060229300A1 (en) 2006-10-12
RU2352566C2 (ru) 2009-04-20
PE20050323A1 (es) 2005-05-16
TWI335915B (en) 2011-01-11
SI1656365T1 (sl) 2009-10-31
ECSP066271A (es) 2006-07-28
UA83666C2 (ru) 2008-08-11
NZ544360A (en) 2008-05-30
HK1086841A1 (en) 2006-09-29
AU2004255874B2 (en) 2010-10-28
PT1656365E (pt) 2009-09-01
ES2327123T3 (es) 2009-10-26
LT5382B (lt) 2006-11-27
IS8184A (is) 2005-12-15
SG144914A1 (en) 2008-08-28
MXPA06000325A (es) 2006-03-30
CA2531165A1 (en) 2005-01-20
TW200510426A (en) 2005-03-16
EP1656365A1 (en) 2006-05-17
PL1656365T3 (pl) 2009-10-30
RS20050972A (en) 2008-06-05
ZA200600019B (en) 2007-01-31
LV13441B (en) 2006-08-20
EP1656365B1 (en) 2009-06-17
JP2009513537A (ja) 2009-04-02
CA2531165C (en) 2011-08-30
AU2004255874A1 (en) 2005-01-20
NO20056175L (no) 2006-01-23
DK1656365T3 (da) 2009-09-14
ATE433965T1 (de) 2009-07-15
BRPI0412447A (pt) 2006-09-19
US20100179319A1 (en) 2010-07-15
CN1820000A (zh) 2006-08-16
JP4668184B2 (ja) 2011-04-13
LT2005107A (en) 2006-06-27
HRP20051019A2 (en) 2006-02-28
WO2005005410A1 (en) 2005-01-20
KR20060056315A (ko) 2006-05-24
RU2006103992A (ru) 2006-06-27

Similar Documents

Publication Publication Date Title
ECSP066271A (es) Un método para la preparación de mirtazapina enantioméricamente pura
IS7319A (is) Fjölgervingar klópídógrelvetnissúlfats
BRPI0611350B8 (pt) formulação, seus usos e seu processo de fabricação,e artigo de fabricação
ECSP055913A (es) Inhibidores de las polimerasas víricas
PE20060165A1 (es) Compuestos con grupo sulfona como inhibidores de secretasa gamma
TW200707131A (en) Photoresist stripper composition and methods for forming wire structures and for fabricating thin film transistor substrate using composition
SV2006002057A (es) Procesos ref. ppd 70440
ATE359334T1 (de) Herstellung von selbstorganisierten monoschichten
DK1652848T3 (da) Fremgangsmåde til fremstilling af imidforbindelse
WO2005026088A3 (de) Verbindungen auf basis von fluoranthen und ihre verwendung
WO2004114371A3 (de) Verbindung zur bildung einer selbstorganisierenden monolage, schichtstruktur, halbleiterbauelement mit einer schichtstruktur und verfahren zur herstellung einer schichtstruktur
AR032381A1 (es) Proceso para mejorar la estabilidad de una composicion farmaceutica
CL2016002556A1 (es) Metodo para recuperar metal desde una solución acuosa utilizando una oxima (divisional solicitud n° 2013-2461)
TW200704630A (en) Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
TW200732843A (en) Photosensitive resin composition and manufacturing method of semiconductor device using the same
TW200612558A (en) Thin layer chemical transistor and its production method
ATE438649T1 (de) Verfahren zur herstellung von dorzolamid
JP2009021575A5 (es)
AR031902A1 (es) Proceso para el aislamiento y la purificacion de epotilonas
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
BRPI0607968A2 (pt) método para preparar um composto de sulfóxido e composto de sulfóxido
ECSP077384A (es) Compuestos tricíclicos que contienen heteroátomos
EP1569287A3 (en) Organic light emitting device materials and organic light emitting devices
TW200420620A (en) Manufacturing method of polymer with sulfoalkyl group

Legal Events

Date Code Title Description
FA Abandonment or withdrawal